Articles

Researchers have devised a better way to determine an individual’s risk for problems, such as myocardial infarction (MI) and heart failure, according to new research….

In a French prospective observational study, older men with higher plasma selenium levels at baseline are less likely to have impaired fasting glucose levels or Type 2 diabetes…

Sixty minutes daily of physical activity seven days a week is recommended for women just to maintain weight….

China has overtaken India as the global epicenter of the diabetes epidemic after a study showed twice as many Chinese are afflicted with the disease as previously estimated….

The modern Western lifestyle is characterized by the consumption of high-heat-treated foods because of their characteristic taste and flavor. However, it has been shown that…

Key results from a landmark federal study are in and the results are disappointing for diabetes patients: adding drugs to drive blood pressure and blood-fats lower than current targets did not prevent heart problems, and in some cases caused harmful side effects.

Researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients. 

In the Action to Control Cardiovascular Risk in Diabetes (ACCORD)-Lipid trial, the combination of fenofibrate and simvastatin, compared with simvastatin alone, failed to reduce cardiovascular events in the majority of patients with Type 2 diabetes at high risk for cardiovascular disease.

The FDA approved Medtronic’s MiniMed Paradigm REAL-Time Revel System, a diabetes management system that combines an insulin pump with a glucose monitoring system. The system may represent the next step toward an artificial pancreas. 

Treatment with salsalate lowers levels of hemoglobin A1c (HbA1c) and improves markers of glycemic control and coronary risk in people with Type 2 diabetes, according to a new study.